Following successful European rollout, more customers to benefit from enhanced local sales and support services Oxford, UK. Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced that it has expanded its direct sales of Cytocell Fluorescence In Situ Hybridisation (FISH) products to include the Asia-Pacific (APAC) region. OGT will provide customers in Singapore, Malaysia, Vietnam, Australia, and New Zealand with enhanced local […]
CAMBRIDGE, Mass – Ultivue, a life science company developing reagent-driven strategies for high-performance biological imaging in situ, today announced expanded capabilities of its proprietary InSituPlex® DNA-barcoding and staining technology. InSituPlex® now supports a higher level of multiplexed detection and quantification of markers in tissue samples while retaining all the benefits of the company’s UltiMapper™ assays. […]
Large-Scale Production of Linear DNA Shows the Best Lot-To-Lot Reproducibility and Sequence Accuracy for Kits Targeting Autoimmunity and Infectious Diseases STONY BROOK, NY. – Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA”), the leader in large-scale PCR-based DNA manufacturing, announced today that LineaRx, Inc. (“LineaRx” or the “Company”) has been providing linear DNA to Technogenetics (Shanghai Kehua Bio-Engineering […]
Launching Test Bed for up to 10-plex assays with Simoa Sensitivity and Specificity to Advance Cancer Research LEXINGTON, Mass.– Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced an Early Access Program for the latest advance in Simoa Sensitivity assays for oncology. The Early Access test bed […]
Expedeon’s proprietary immunoassay technology to be incorporated into Quanterix’ Simoa Planar Immunoassay products Heidelberg, Germany and Cambridge, UK – Expedeon AG (Frankfurt: EXN; ISIN: DE000A1RFM03; Prime Standard) today announced a supply and license agreement with United States based Life Sciences company, Quanterix Corporation. The agreement provides Quanterix access to Expedeon’s breadth of immunoassay technologies for application […]
El Segundo, CA – BioDiscovery, Inc., a leader in integrated software solutions for genomic data analysis, announced today that PerkinElmer Genomics has selected the company’s NxClinical software as its choice for genomic data analysis for its services. PerkinElmer Genomics is a worldwide leader in providing families and healthcare professionals access to insightful genomic data when making difficult medical decisions. […]
NATICK, MASS. ThermaGenix, Inc. introduces FASTFISH-ID, a low-cost portable DNA Test for Authentication of Commercial Fish Species. This PCR-based single-tube test provides rapid authentication of any species of Commercial Fish in one easy-to-use process on a portable device in about two hours. FASTFISH-ID is fully compatible with the FDA-approved DNA-Barcoding Method for the Species Identification […]
Company introduces enhanced Arima-HiC product offering to drive greater insights for chromatin conformation and genome assembly studies SAN DIEGO– Arima Genomics, Inc., a biotechnology company empowering researchers to apply long-range genetic sequence and structure information towards the understanding of health, disease and species evolution, announced today the full commercial launch of its Arima-HiC technology. The […]
MANASSAS, Va. — Reinforcing its long-established reputation for quality and reliability as the steward for credible biomaterial and standards in the biological sciences, ATCC today announced details of its new initiative, Incredible 2020. Building on ATCC’s non-profit mission, this Incredible 2020 initiative, which was unveiled at the Society for Neuroscience (SfN) 2018 annual conference in San Diego, CA, […]
AMSBIO has expanded its range of high quality FFPE cancer cell line controls for immunohistochemistry (IHC), in situ hybridization (ISH) and Next Generation Sequencing (NGS) applications. Variations in FFPE tissue sample quality and experimental setup can lead to misleading results without reliable controls. Traditional cell or tissue-based control specimens often present intra specimen variation, lot-to-lot variations […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
